对于IgG4相关的长期视神经病变的成功葡萄糖皮质激素治疗案例
Soma Fukami1, Shin-Ichiro Ohmura1, Toshitaka Yukishima1
1Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
Modern rheumatology case reports
|March 6, 2025
概括
免疫球蛋白G4相关的眼部疾病 (IgG4-ROD) 可以导致视神经病变. 这种罕见的疾病,即使长期存在,也可能导致不可逆转的视力丧失,强调需要及时诊断和治疗.
科学领域:
- 类风湿病学 类风湿病学
- 眼科医生 眼科 眼科
- 神经学 神经学
背景情况:
- 免疫球蛋白G4相关疾病 (IgG4-RD) 是一种全身性疾病,由于IgG4阳性血细胞透,导致器官胀.
- 与IgG4相关的眼病 (IgG4-ROD) 是IgG4-RD的眼部表现,可能会影响视神经.
- 在IgG4-ROD中,视神经病变会导致逐渐的视力损伤和永久的视力损失,如果不及时诊断和治疗.
研究的目的:
- 报告一个罕见的长期视神经病变的罕见病例,这是IgG4-ROD的次要原因.
- 讨论在这个特定情况下的临床过程和视觉预后.
主要方法:
- 案例报告的呈现方式.
- 对临床病史和视觉结果的审查.
主要成果:
- 该患者出现了长期存在的视神经病变,归因于IgG4-ROD.
- 这种情况导致光感完全丧失,这表明这种严重,持续的病例的视觉预后不佳.
结论:
- 视神经病变是一种罕见但严重的IgG4-ROD并发症.
- 延迟IgG4-ROD的诊断和治疗可能导致不可逆转的视力损伤,强调早期识别和干预的重要性.
相关概念视频
Open Angle Glaucoma: Treatment
383
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
383
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Angle Closure Glaucoma: Treatment
425
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
425
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
Glaucoma: Overview
493
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
493
Inflammatory Bowel Disease IV: Pharmacological Management
86
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
86


